Bone Marrow Transplantation and Immune Deficiency

Fig A: These magnetic resonance images show responses in two patients with recurrent sonic hedgehog–subgroup medullo-blastoma (MB) treated with vismodegib. Images were obtained at the start of therapy and at 2, 4, and 6 months after. Gold arrows indicate recurrent lesions. After initial response, MB recurs locally.

Featured Research

Vismodegib Shows Promise in Recurrent Medulloblastoma Sonic Hedgehog Subgroup

A drug that has helped some people with basal cell carcinoma also shows promise as an improved therapy for a subgroup of people with recurrent medulloblastomas.

Read More

Division Summary

Research and Training Details

Faculty15
Joint Appointment Faculty4
Research Fellows and Post Docs1
Research Graduate Students1
Total Annual Grant Award Dollars$1,284,076
Total Annual Industry Award Dollars$257,680
Total Publications51

Clinical Activities and Training

Staff Physicians9
Clinical Fellows5
Inpatient Encounters11,502
Outpatient Encounters7,482